[
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "I",
        "alt": "T",
        "position": "2020"
      },
      "variant_string_id": "LRRK2 I2020T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper describes that higher susceptibility of I2020T mutant LRRK2 to intracellular degradation than the wild-type molecule may be one of the mechanisms involved in the neurodegeneration associated with this LRRK2 mutation.",
        "judgment": "Yes",
        "reasoning": "The paper discusses a molecular mechanism (higher susceptibility to intracellular degradation) that is relevant to the functional assay (protectivity against apoptosis)."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "The paper uses a cell phenotype rescue assay (protectivity against apoptosis) to model or reflect the disease pathogenesis/mechanism defined in Step 1.",
        "judgment": "Yes"
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "sub_steps": [
          {
            "sub_step_number": "3a",
            "questions": [
              {
                "question": "Were basic controls included for this assay? Specifically, were both 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                "answer": "Yes"
              },
              {
                "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                "answer": "Yes"
              }
            ]
          },
          {
            "sub_step_number": "3c",
            "questions": [
              {
                "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
                "answer": "Not explicitly stated"
              },
              {
                "question": "Were variant controls used in the assay for this variant? Specifically, were known benign variants used as controls?",
                "answer": "Not explicitly stated"
              }
            ]
          }
        ]
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "sub_steps": [
          {
            "sub_step_number": "4a",
            "questions": [
              {
                "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                "answer": "Not explicitly stated"
              }
            ]
          },
          {
            "sub_step_number": "4b",
            "questions": [
              {
                "question": "How many total benign/pathogenic variant controls were used across the entire study (as applicable to this variant's assay)?",
                "answer": "Not explicitly stated"
              }
            ]
          },
          {
            "sub_step_number": "4c",
            "questions": []
          }
        ]
      }
    ],
    "functional_evidence_strength": "Max PS3_supporting"
  }
]